{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T16:12:53Z","timestamp":1776442373582,"version":"3.51.2"},"reference-count":137,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"FUNDA\u00c7\u00c3O PARA A CI\u00caNCIA E TECNOLOGIA (FCT-PORTUGAL)","award":["UIDB\/00313\/2020"],"award-info":[{"award-number":["UIDB\/00313\/2020"]}]},{"name":"FUNDA\u00c7\u00c3O PARA A CI\u00caNCIA E TECNOLOGIA (FCT-PORTUGAL)","award":["UIDP\/00313\/2020"],"award-info":[{"award-number":["UIDP\/00313\/2020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Magnetic nanoparticles (MNPs), either paramagnetic or superparamagnetic depending on their composition and size, have been thoroughly studied as magnetic resonance imaging (MRI) contrast agents using in vitro and in vivo biomedical preclinical studies, while some are clinically used. Their magnetic properties responsible in some cases for high magnetization values, together with large surface area-to-volume ratios and the possibility of surface functionalization, have been used in MRI-based diagnostic and theranostics applications. MNPs are usually used as positive (T1) or negative (T2) MRI contrast agents, causing brightening or darkening of selected regions in MRI images, respectively. This review focusses on recent developments and optimization of MNPs containing Gd, Mn, Fe and other lanthanide ions which may function as dual-mode T1\u2013T2 MRI contrast agents (DMCAs). They induce positive or negative contrast in the same MRI scanner upon changing its operational mode between T1-weighted and T2-weighted pulse sequences. The type of contrast they induce depends critically on their r2\/r1 relaxivity ratio, which for DMCAs should be in the 2\u201310 range of values. After briefly discussing the basic principles of paramagnetic relaxation in MNPs, in this review, the basic strategies for the rational design of DMCAs are presented and typical examples are discussed, including in vivo preclinical applications: (1) the use of NPs with a single type of contrast material, Gd- or Mn-based NPs or superparamagnetic NPs with appropriate size and magnetization to provide T2 and T1 contrast; and (2) inclusion of both types of T1 and T2 contrast materials in the same nanoplatform by changing their relative positions.<\/jats:p>","DOI":"10.3390\/molecules29061352","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T04:36:31Z","timestamp":1710822991000},"page":"1352","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Rational Design of Magnetic Nanoparticles as T1\u2013T2 Dual-Mode MRI Contrast Agents"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0837-8329","authenticated-orcid":false,"given":"Carlos F. G. C.","family":"Geraldes","sequence":"first","affiliation":[{"name":"Department of Life Sciences and Coimbra Chemistry Center (CQC-IMS), Faculty of Science and Technology, University of Coimbra, 3004-531 Coimbra, Portugal"},{"name":"CIBIT\u2014Coimbra Institute for Biomedical Imaging and Translational Research, University of Coimbra, 3004-531 Coimbra, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Reimer, P., Parizel, P.M., Meaney, J.F.M., and Stichnoth, F.A. (2010). Clinical MR Imaging, a Practical Approach, Springer.","DOI":"10.1007\/978-3-540-74504-4"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1148\/radiology.219.2.r01ma19316","article-title":"Molecular imaging","volume":"219","author":"Weissleder","year":"2001","journal-title":"Radiology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1021\/cr980440x","article-title":"Gadolinium (III) Chelates as MRI Contrast Agents:\u2009 Structure, Dynamics, and Applications","volume":"99","author":"Caravan","year":"1999","journal-title":"Chem. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Merbach, A.E., Helm, L., and T\u00f3th, \u00c9. (2013). The Chemistry of Contrast Agents in Medical Magnetic Resonance Imaging, John Wiley & Sons Ltd.. [2nd ed.].","DOI":"10.1002\/9781118503652"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1021\/acs.chemrev.8b00363","article-title":"Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers","volume":"119","author":"Wahsner","year":"2019","journal-title":"Chem. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0898-8838(05)57004-1","article-title":"Gd(III)-Based Contrast Agents for MRI","volume":"57","author":"Aime","year":"2005","journal-title":"Adv. Inorg. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cmmi.265","article-title":"Classification and basic properties of contrast agents for magnetic resonance imaging","volume":"4","author":"Geraldes","year":"2009","journal-title":"Contrast Media Mol. Imaging"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nature06917","article-title":"Imaging in the era of molecular oncology","volume":"452","author":"Weissleder","year":"2008","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1039\/C4CS00293H","article-title":"Using lanthanide ions in molecular bioimaging","volume":"44","author":"Amoroso","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1021\/cr900232t","article-title":"Macromolecules, Dendrimers, and Nanomaterials in Magnetic Resonance Imaging: The Interplay between Size, Function, and Pharmacokinetics","volume":"110","author":"Villaraza","year":"2010","journal-title":"Chem. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1021\/cr068445e","article-title":"Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications","volume":"108","author":"Laurent","year":"2008","journal-title":"Chem. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1039\/C1CS15248C","article-title":"Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents","volume":"41","author":"Lee","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"10637","DOI":"10.1021\/acs.chemrev.5b00112","article-title":"Iron Oxide Based Nanoparticles for Multimodal Imaging and Magnetoresponsive Therapy","volume":"115","author":"Lee","year":"2015","journal-title":"Chem. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1002\/jmri.21966","article-title":"Primer on gadolinium chemistry","volume":"30","author":"Sherry","year":"2009","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00330-012-2597-9","article-title":"Nephrogenic systemic fibrosis and gadolinium-based contrast media: Updated ESUR Contrast Medium Safety Committee guidelines","volume":"23","author":"Thomsen","year":"2013","journal-title":"Eur. Radiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.rcl.2009.05.003","article-title":"Nephrogenic Systemic Fibrosis: History and Epidemiology","volume":"47","author":"Thomsen","year":"2009","journal-title":"Radiol. Clin. N. Am."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.berh.2012.07.008","article-title":"Nephrogenic systemic fibrosis: A systemic fibrosing disease resulting from gadolinium exposure","volume":"26","author":"Berstein","year":"2012","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiol.2017162857","article-title":"Gadolinium Retention in the Rat Brain: Assessment of the Amounts of Insoluble Gadolinium-containing Species and Intact Gadolinium Complexes after Repeated Administration of Gadolinium-based Contrast Agents","volume":"285","author":"Gianolio","year":"2017","journal-title":"Radiology"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Khairinisa, M.A., Ariyani, W., Tsushima, Y., and Koibuchi, N. (2021). Effects of gadolinium deposits in the cerebellum: Reviewing the literature from in vitro laboratory studies to in vivo human investigations. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18147214"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.21037\/qims.2017.02.09","article-title":"A comprehensive literature update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging","volume":"7","author":"Wang","year":"2017","journal-title":"Quant. Imaging Med. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1039\/c2cs15260f","article-title":"The unique role of nanoparticles in nanomedicine: Imaging, drug delivery and therapy","volume":"41","author":"Doane","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.pnmrs.2006.03.003","article-title":"Relaxivity in paramagnetic systems: Theory and mechanisms","volume":"49","author":"Helm","year":"2006","journal-title":"Prog. Nucl. Magn. Reson. Spectrosc."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pnmrs.2010.08.002","article-title":"MRI contrast agents based on dysprosium or holmium","volume":"59","author":"Norek","year":"2011","journal-title":"Prog. Nucl. Magn. Reason. Spectrosc."},{"key":"ref_24","unstructured":"Bertini, I., Luchinat, C., Parigi, G., and Ravera, E. (2017). NMR of Paramagnetic Molecules, Elsevier. [2nd ed.]."},{"key":"ref_25","first-page":"58","article-title":"Nuclear relaxation in macromolecules by paramagnetic ions: A novel mechanism","volume":"19","author":"Gueron","year":"1975","journal-title":"J. Magn. Reson."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/00268977600100261","article-title":"Nuclear relaxation processes of paramagnetic complexes-The slow-motion case","volume":"31","author":"Vega","year":"1976","journal-title":"Mol. Phys."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1063\/1.478435","article-title":"Theory of proton relaxation induced by superparamagnetic particles","volume":"110","author":"Roch","year":"1999","journal-title":"J. Chem. Phys."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/adhm.201200078","article-title":"A Universal Scaling Law to Predict the Efficiency of Magnetic Nanoparticles as MRI T2-Contrast, Agents","volume":"1","author":"Vuong","year":"2012","journal-title":"Adv. Healthc. Mater."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"114505","DOI":"10.1063\/1.4751442","article-title":"New simulation approach using classical formalism to water nuclear magnetic relaxation dispersions in presence of superparamagnetic particles used as MRI contrast agents","volume":"137","author":"Vuong","year":"2012","journal-title":"J. Chem. Phys."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Brown, M.A., and Semalka, R.C. (2003). MRI: Basic Principles and Applications, Wiley-Liss.","DOI":"10.1002\/0471467936"},{"key":"ref_31","first-page":"1727","article-title":"Nanoparticles in magnetic resonance imaging: From simple to dual contrast agents","volume":"10","author":"Estelrich","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/wnan.1243","article-title":"Paramagnetic inorganic nanoparticles as T1 MRI contrast agents","volume":"6","author":"Lee","year":"2014","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1021\/ja068356j","article-title":"Hybrid gadolinium oxide nanoparticles: Multimodal contrast agents for in vivo imaging","volume":"129","author":"Bridot","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"69861","DOI":"10.1039\/C5RA09374K","article-title":"Molecular architecture control in synthesis of spherical Ln-containing nanoparticles","volume":"5","author":"Zhang","year":"2015","journal-title":"RSC Adv."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1039\/C3NR03982J","article-title":"Gadolinium oxysulfide nanoparticles as multimodal imaging agents for T2-weighted MR, X-ray tomography and photoluminescence","volume":"6","author":"Osseni","year":"2014","journal-title":"Nanoscale"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"8004","DOI":"10.1002\/chem.201200472","article-title":"Microwave-assisted seeded growth of lanthanide-based nanoparticles for imaging and therapy","volume":"18","author":"Mayer","year":"2012","journal-title":"Chem. Eur. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1021\/cm101036a","article-title":"Polymer-Stabilized Lanthanide Fluoride Nanoparticle Aggregates as Contrast Agents for Magnetic Resonance Imaging and Computed Tomography","volume":"22","author":"Cheung","year":"2010","journal-title":"Chem. Mater."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1021\/cm052299w","article-title":"Water-soluble GdF3 and GdF3\/LaF3 nanoparticles-physical characterization and NMR relaxation properties","volume":"18","author":"Evanics","year":"2006","journal-title":"Chem. Mater."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"15090","DOI":"10.1021\/ja066442d","article-title":"Gadolinium-based hybrid nanoparticles as a positive MR contrast agent","volume":"128","author":"Hifumi","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1039\/C5NR05064B","article-title":"Hyperbranched polymer mediated size-controlled synthesis of gadolinium phosphate nanoparticles: Colloidal properties and particle size-dependence on MRI relaxivity","volume":"8","author":"Frangville","year":"2016","journal-title":"Nanoscale"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1021\/nn900761s","article-title":"Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: Account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images","volume":"3","author":"Park","year":"2009","journal-title":"ACS Nano"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1039\/D1NJ00508A","article-title":"A design strategy of ultrasmall Gd2O3 nanoparticles for T1 MRI with high performance","volume":"45","author":"Yang","year":"2021","journal-title":"New J. Chem."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.nano.2017.12.005","article-title":"Comparative study on in vivo behavior of PEGylated gadolinium oxide nanoparticles and Magnevist as MRI contrast agent","volume":"14","author":"Dai","year":"2018","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5755","DOI":"10.1002\/adma.201202433","article-title":"Theranostic probe based on lanthanide-doped nanoparticles for simultaneous in vivo dual-modal imaging and photodynamic therapy","volume":"24","author":"Park","year":"2012","journal-title":"Adv. Mater."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.1016\/j.tet.2011.07.076","article-title":"Manganese-based MRI contrast agents: Past, present and future","volume":"67","author":"Pan","year":"2011","journal-title":"Tetrahedron"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"8321","DOI":"10.2147\/IJN.S218085","article-title":"Manganese Oxide Nanoparticles as MRI Contrast Agents in tumour multimodal imaging and therapy","volume":"14","author":"Cai","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"51905823","DOI":"10.1002\/adma.201905823","article-title":"Manganese Oxide Nanomaterials: Synthesis, Properties, and Theranostic Applications","volume":"32","author":"Ding","year":"2020","journal-title":"Adv. Mater."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/anie.200802323","article-title":"Hollow Manganese Oxide Nanoparticles as Multifunctional Agents for Magnetic Resonance Imaging and Drug Delivery","volume":"48","author":"Shin","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1021\/acsami.1c20617","article-title":"Zwitterion-Coated Ultrasmall MnO Nanoparticles Enable Highly Sensitive T1-Weighted Contrast-Enhanced Brain Imaging","volume":"14","author":"Wei","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bios.2017.10.047","article-title":"One-pot preparation of hydrophilic manganese oxide nanoparticles as T1 nano-contrast agent for molecular magnetic resonance imaging of renal carcinoma in vitro and in vivo","volume":"102","author":"Li","year":"2018","journal-title":"Biosens. Bioelectron."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1038\/srep03424","article-title":"Ultrahigh relaxivity and safe probes of manganese oxide nanoparticles for in vivo imaging","volume":"3","author":"Xiao","year":"2013","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Botta, M., Geraldes, C.F.G.C., and Tei, L. (2022). High spin Fe(III)-doped nanostructures as T1 MR imaging probes. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 15.","DOI":"10.1002\/wnan.1858"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1038\/ncomms3266","article-title":"Octapod iron oxide nanoparticles as high-performance T2 contrast agents for magnetic resonance imaging","volume":"4","author":"Zhao","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"28959","DOI":"10.1021\/acsami.7b10030","article-title":"Ultrasmall Superparamagnetic Iron Oxide Nanoparticle for T2-Weighted Magnetic Resonance Imaging","volume":"9","author":"Wang","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"76883","DOI":"10.1039\/C5RA15680G","article-title":"In vivo pharmacokinetics of T2 contrast agents based on iron oxide nanoparticles: Optimization of blood circulation times","volume":"5","author":"Leal","year":"2015","journal-title":"RSC Adv."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1021\/nl3010308","article-title":"Water-dispersible ferrimagnetic iron oxide nanocubes with extremely high r2 relaxivity for highly sensitive in vivo MRI of tumors","volume":"12","author":"Lee","year":"2012","journal-title":"Nano Lett."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1021\/acsanm.1c00569","article-title":"PEGylated Terbium-Based Nanorods as Multimodal Bioimaging Contrast Agents","volume":"4","author":"Caro","year":"2021","journal-title":"ACS Appl. Nano Mater."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"9249","DOI":"10.1021\/acsnano.7b04472","article-title":"Dysprosium-Modified Tobacco Mosaic Virus Nanoparticles for Ultra-High-Field Magnetic Resonance and Near-Infrared Fluorescence Imaging of Prostate Cancer","volume":"11","author":"Hu","year":"2017","journal-title":"ACS Nano"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"21041","DOI":"10.1039\/C8NR07198E","article-title":"Dy-DOTA integrated mesoporous silica nanoparticles as promising ultrahigh field magnetic resonance imaging contrast agents","volume":"10","author":"Zheng","year":"2018","journal-title":"Nanoscale"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.biomaterials.2015.10.063","article-title":"PEGylated NaHoF4 nanoparticles as contrast agents for both X-ray computed tomography and ultra-high field magnetic resonance imaging","volume":"76","author":"Ni","year":"2016","journal-title":"Biomaterials"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/mrm.1277","article-title":"Molecular factors that determine Curie spin relaxation in dysprosium complexes","volume":"46","author":"Caravan","year":"2001","journal-title":"Magn. Reson. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5335","DOI":"10.1021\/ja711492y","article-title":"Tuning of the size of Dy2O3 nanoparticles for optimal performance as an MRI contrast agent","volume":"130","author":"Norek","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1021\/ar100129p","article-title":"Lanthanide-doped nanocrystals: Synthesis, optical-magnetic properties, and applications","volume":"44","author":"Wang","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1021\/jz201664h","article-title":"NaDyF4 Nanoparticles as T2 Contrast Agents for Ultrahigh Field Magnetic Resonance Imaging","volume":"3","author":"Das","year":"2012","journal-title":"J. Phys. Chem. Lett."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1021\/ar700121f","article-title":"Nanoscaling Laws of Magnetic Nanoparticles and Their Applicabilities in Biomedical Sciences","volume":"41","author":"Jun","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.addr.2008.03.014","article-title":"Multifunctional magnetic nanoparticles for targeted imaging and therapy","volume":"60","author":"McCarthy","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1021\/ar9000026","article-title":"Multifunctional Magnetic Nanoparticles: Design, Synthesis, and Biomedical Applications","volume":"42","author":"Gao","year":"2009","journal-title":"Acc. Chem. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"10491","DOI":"10.1039\/C6NR00267F","article-title":"The evolution of gadolinium-based contrast agents: From single-modality to multi-modality","volume":"8","author":"Zhang","year":"2016","journal-title":"Nanoscale"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1021\/ar200085c","article-title":"Theranostic Magnetic Nanoparticles","volume":"44","author":"Yoo","year":"2011","journal-title":"Acc. Chem. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"12687","DOI":"10.1039\/c2cp41357d","article-title":"Paramagnetic nanoparticle T1 and T2 MRI contrast agents","volume":"14","author":"Xu","year":"2012","journal-title":"Phys. Chem. Chem. Phys."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1021\/acsnano.7b03075","article-title":"T1\u2013T2 Dual-Modal Magnetic Resonance Imaging: From Molecular Basis to Contrast Agents","volume":"11","author":"Zhou","year":"2017","journal-title":"ACS Nano"},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Tegafaw, S.L., Ahmad, M.Y., Al Saidi, A.K.A., Zhao, D., Liu, Y., Nam, S.-W., Chang, Y., and Lee, G.H. (2023). Magnetic Nanoparticle-Based High-Performance Positive and Negative Magnetic Resonance Imaging Contrast Agents. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15061745"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"9119","DOI":"10.1002\/anie.201203190","article-title":"Hydrogels Incorporating GdDOTA: Towards Highly Efficient Dual T1\/T2 MRI Contrast Agents","volume":"51","author":"Courant","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Marasini, S., Yue, H., Ghazanfari, A., Ho, S.L., Park, J.A., Kim, S., Cha, H., Liu, S., Tegafaw, T., and Ahmad, M.Y. (2021). Polyaspartic Acid-Coated Paramagnetic Gadolinium Oxide Nanoparticles as a Dual-Modal T1 and T2 Magnetic Resonance Imaging Contrast Agent. Appl. Sci., 11.","DOI":"10.3390\/app11178222"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"6782","DOI":"10.1021\/acsami.6b14075","article-title":"Encapsulation of Gadolinium Oxide Nanoparticle (Gd2O3) Contrasting Agents in PAMAM Dendrimer Templates for Enhanced Magnetic Resonance Imaging in vivo","volume":"9","author":"Mekuria","year":"2017","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1039\/C7NR01134B","article-title":"Albumin-Based Nanoparticles Loaded with Hydrophobic Gadolinium Chelates as T1\u2212T2 Dual-Mode Contrast Agents for Accurate Liver Tumor Imaging","volume":"9","author":"Wang","year":"2017","journal-title":"Nanoscale"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"9942","DOI":"10.1021\/am401856w","article-title":"Manganese-loaded dual-mesoporous silica spheres for efficient T1- and T2-weighted dual mode magnetic resonance imaging","volume":"5","author":"Niu","year":"2013","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"e202206074","DOI":"10.1002\/anie.202206074","article-title":"Overcoming Hypoxia-Induced Ferroptosis Resistance via a 19F\/1HMRI Traceable Core-Shell Nanostructure","volume":"61","author":"Dong","year":"2022","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1007\/s12274-022-4877-4","article-title":"Manganese-doped mesoporous polydopamine nanoagent for T1\u2013T2 magnetic resonance imaging and tumor therapy","volume":"16","author":"Hou","year":"2023","journal-title":"Nano Res."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"365102","DOI":"10.1088\/0957-4484\/26\/36\/365102","article-title":"Dual-mode T1 and T2 magnetic resonance imaging contrast agent based on ultrasmall mixed gadolinium-dysprosium oxide nanoparticles: Synthesis, characterization, and in vivo application","volume":"26","author":"Tegafaw","year":"2015","journal-title":"Nanotechnology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"15680","DOI":"10.1039\/C5NR04065E","article-title":"An ultrasmall and metabolizable PEGylated NaGdF4:Dy nanoprobe for high-performance T1\/T2-weighted MR and CT multimodal imaging","volume":"7","author":"Jin","year":"2015","journal-title":"Nanoscale"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.biomaterials.2015.11.010","article-title":"Polydopamine-Based Coordination Nanocomplex for T1\/T2 Dual Mode Magnetic Resonance Imaging-Guided Chemo-Photothermal Synergistic Therapy","volume":"77","author":"Chen","year":"2016","journal-title":"Biomaterials"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"38819","DOI":"10.1021\/acsami.8b15594","article-title":"Dual T1\/T2 Nanoscale Coordination Polymers as Novel Contrast Agents for MRI: A Preclinical Study for Brain Tumor","volume":"10","author":"Frias","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"49568","DOI":"10.1021\/acsami.2c15295","article-title":"Hofmeister Effect-Based T1\u2212T2 Dual-Mode MRI and Enhanced Synergistic Therapy of Tumor","volume":"14","author":"Chen","year":"2022","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1002\/adfm.201103123","article-title":"Ultrasmall Water-Soluble and Biocompatible Magnetic Iron Oxide Nanoparticles as Positive and Negative Dual Contrast Agents","volume":"22","author":"Li","year":"2012","journal-title":"Adv. Funct. Mater."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1039\/c3nr05550g","article-title":"One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging","volume":"6","author":"Wang","year":"2014","journal-title":"Nanoscale"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1039\/C9TB00002J","article-title":"A T1\/T2 dual functional iron oxide MRI contrast agent with super stability and low hypersensitivity benefited by ultrahigh carboxyl group density","volume":"7","author":"Miao","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e2004917","DOI":"10.1002\/adma.202004917","article-title":"An Ultrahigh-Field-Tailored T1\u2013T2 Dual-Mode MRI Contrast Agent for High-Performance Vascular Imaging","volume":"33","author":"Wang","year":"2021","journal-title":"Adv Mater."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"7976","DOI":"10.1021\/nn5038652","article-title":"Interplay between longitudinal and transverse contrasts in Fe3O4 nanoplates with (111) exposed surfaces","volume":"8","author":"Zhou","year":"2014","journal-title":"ACS Nano"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"10519","DOI":"10.1039\/C5NR00752F","article-title":"Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T1\u2013T2 MRI contrast agents","volume":"7","author":"Sharma","year":"2015","journal-title":"Nanoscale"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1021\/acsabm.8b00016","article-title":"T1- and T2-weighted Magnetic Resonance Dual Contrast by Single Core Truncated Cubic Iron Oxide Nanoparticles with Abrupt Cellular Internalization and Immune Evasion","volume":"1","author":"Thapa","year":"2018","journal-title":"ACS Appl. Bio. Mater."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1021\/acs.nanolett.8b04411","article-title":"Dynamically Reversible Iron Oxide Nanoparticle Assemblies for Targeted Amplification of T1-Weighted Magnetic Resonance Imaging of Tumors","volume":"19","author":"Li","year":"2019","journal-title":"Nano Lett."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1901800","DOI":"10.1002\/advs.201901800","article-title":"Light-Addressable Nanoclusters of Ultrasmall Iron Oxide Nanoparticles for Enhanced and Dynamic Magnetic Resonance Imaging of Arthritis","volume":"6","author":"Li","year":"2019","journal-title":"Adv. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"17502","DOI":"10.1039\/D0NR04201C","article-title":"Synergistic regulation of longitudinal and transverse relaxivity of extremely small iron oxide nanoparticles (ESIONPs) using pH-responsive nanoassemblies","volume":"12","author":"Cao","year":"2020","journal-title":"Nanoscale"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1039\/D0TB02411B","article-title":"Redox-triggered aggregation of ESIONPs with switchable T1 to T2 contrast effect for T2-weighted magnetic resonance imaging","volume":"9","author":"He","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"15826","DOI":"10.1021\/acsanm.2c03971","article-title":"Extremely Small Iron Oxide Nanoparticles with pH-Dependent Solubility Transition as T1\/T2 Switchable Contrast Agents for MRI","volume":"5","author":"He","year":"2022","journal-title":"ACS Appl. Nano Mater."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"7752","DOI":"10.1021\/acsabm.0c00958","article-title":"Tumor Acid Microenvironment-Triggered Self-Assembly of ESIONPs for T1\/T2 Switchable Magnetic Resonance Imaging","volume":"3","author":"He","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1021\/acsnano.7b00038","article-title":"Exerting Enhanced Permeability and Retention Effect Driven Delivery by Ultrafine Iron Oxide Nanoparticles with T1\u2013T2 Switchable Magnetic Resonance Imaging Contrast","volume":"11","author":"Wang","year":"2017","journal-title":"ACS Nano"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"7734","DOI":"10.1039\/D1TB01018B","article-title":"Fe3O4 assembly for tumor accurate diagnosis by endogenous GSH responsive T2\/T1 magnetic relaxation conversion","volume":"9","author":"Wang","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1039\/C7NR00089H","article-title":"In vivo aggregation-induced transition between T1 and T2 relaxations of magnetic ultra-small iron oxide nanoparticles in tumor microenvironment","volume":"9","author":"Zhou","year":"2017","journal-title":"Nanoscale"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"9625","DOI":"10.1021\/acsanm.2c01835","article-title":"Ultrasmall Superparamagnetic Iron Oxide Nanoparticles as Nanocarriers for Magnetic Resonance Imaging: Development and In Vivo Characterization","volume":"5","author":"Si","year":"2022","journal-title":"ACS Appl. Nano Mater."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nmat4846","article-title":"Distance-dependent magnetic resonance tuning as a versatile MRI sensing platform for biological targets","volume":"16","author":"Choi","year":"2017","journal-title":"Nat. Mater."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"6223","DOI":"10.1002\/adma.201203169","article-title":"A Synergistically Enhanced T1\u2013T2 Dual-Modal Contrast Agent","volume":"24","author":"Zhou","year":"2012","journal-title":"Adv. Mater."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1016\/j.biomaterials.2004.10.012","article-title":"Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications","volume":"26","author":"Gupta","year":"2005","journal-title":"Biomaterials"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"11015","DOI":"10.1021\/ja104503g","article-title":"Self-confirming \u201cAND\u201d logic nanoparticles for fault-free MRI","volume":"132","author":"Choi","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.talanta.2014.08.042","article-title":"Characterization of Fe3O4\/SiO2\/Gd2O(CO3)2 core\/shell\/shell nanoparticles as T1 and T2 dual mode MRI contrast agent","volume":"131","author":"Yang","year":"2015","journal-title":"Talanta"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.2147\/IJN.S168660","article-title":"T1\u2013T2 molecular magnetic resonance imaging of renal carcinoma cells based on nano-contrast agents","volume":"13","author":"Li","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"12826","DOI":"10.1039\/C6NR02620F","article-title":"Core\/shell Fe3O4\/Gd2O3 nanocubes as T1\u2013T2 dual modal MRI contrast agents","volume":"8","author":"Li","year":"2016","journal-title":"Nanoscale"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.biomaterials.2012.11.054","article-title":"Fe3O4\/MnO hybrid nanocrystals as a dual contrast agent for both T1- and T2-weighted liver MRI","volume":"34","author":"Im","year":"2013","journal-title":"Biomaterials"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.biomaterials.2016.05.054","article-title":"Redoxable heteronanocrystals functioning magnetic relaxation switch for activatable T1 and T2 dual-mode magnetic resonance imaging","volume":"101","author":"Kim","year":"2016","journal-title":"Biomaterials"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"31947","DOI":"10.1021\/acsami.8b10564","article-title":"Ternary-Responsive Drug Delivery with Activatable Dual Mode Contrast Enhanced in vivo Imaging","volume":"10","author":"Ren","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.1021\/nn405977t","article-title":"T1 and T2 dual-mode MRI contrast agent for enhancing accuracy by engineered nanomaterials","volume":"8","author":"Shin","year":"2014","journal-title":"ACS Nano"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"16119","DOI":"10.1039\/C5NR04400F","article-title":"Tuning the relaxation rates of dual-mode T1\/T2 nanoparticle contrast agents: A study into the ideal system","volume":"7","author":"Keasberry","year":"2015","journal-title":"Nanoscale"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1021\/bc900424u","article-title":"Bioinspired Synthesis and Characterization of Gadolinium-Labeled Magnetite Nanoparticles for Dual Contrast T1- and T2-Weighted Magnetic Resonance Imaging","volume":"21","author":"Bae","year":"2010","journal-title":"Bioconjug. Chem."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1039\/C5TB00041F","article-title":"Multifunctional gadolinium-labeled silica-coated Fe3O4 and CuInS2 nanoparticles as a platform for in vivo tri-modality magnetic resonance and fluorescence imaging","volume":"3","author":"Shen","year":"2015","journal-title":"J. Mater. Chem. B"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1039\/c4tb00342j","article-title":"Controlled synthesis of MnFe2O4 nanoparticles and Gd complex-based nanocomposites as tunable and enhanced T1\/T2-weighted MRI contrast agents","volume":"2","author":"Wang","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1016\/j.biomaterials.2011.03.018","article-title":"Targeted dual contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles","volume":"32","author":"Yang","year":"2011","journal-title":"Biomaterials"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"16618","DOI":"10.1021\/acs.inorgchem.9b02655","article-title":"Gd- and Eu-Loaded Iron Oxide@Silica Core\u2212Shell Nanocomposites as Trimodal Contrast Agents for Magnetic Resonance Imaging and Optical Imaging","volume":"58","author":"Pinho","year":"2019","journal-title":"Inorg. Chem."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.mri.2007.04.006","article-title":"Comparative analysis of the 1H NMR relaxation enhancement produced by iron oxide and core-shell iron\u2013iron oxide nanoparticles","volume":"25","author":"Gossuin","year":"2007","journal-title":"Magn. Reson. Imaging"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"26764","DOI":"10.1039\/C8RA04530E","article-title":"Gadolinium-labelled iron\/iron oxide core\/shell nanoparticles as T1\u2013T2 contrast agent for magnetic resonance imaging","volume":"8","author":"Wang","year":"2018","journal-title":"RSC Adv."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1021\/acs.nanolett.0c00817","article-title":"Dual-Mode Avocado-like All-Iron Nanoplatform for Enhanced T1\/T2 MRI-Guided Cancer Theranostic Therapy","volume":"20","author":"Li","year":"2020","journal-title":"Nano Lett."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jmmm.2006.10.1188","article-title":"Enhanced ferrite nanoparticles as MRI contrast agents","volume":"311","author":"Shultz","year":"2007","journal-title":"J. Magn. Magn. Mater."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1039\/c3nr02797j","article-title":"Gadolinium embedded iron oxide nanoclusters as T1\u2013T2 dual-modal MRI-visible vectors for safe and efficient siRNA delivery","volume":"5","author":"Wang","year":"2013","journal-title":"Nanoscale"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1021\/nn305991e","article-title":"Engineered Iron-Oxide-Based Nanoparticles as Enhanced T1 Contrast Agents for Efficient Tumor Imaging","volume":"7","author":"Zhou","year":"2013","journal-title":"ACS Nano"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"10404","DOI":"10.1039\/C4NR02680B","article-title":"Tunable T1 and T2 contrast abilities of manganese-engineered iron oxide nanoparticles through size control","volume":"6","author":"Huang","year":"2014","journal-title":"Nanoscale"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.1039\/C5NR00774G","article-title":"Europium-engineered iron oxide nanocubes with high T1 and T2 contrast abilities for MRI in living subjects","volume":"7","author":"Yang","year":"2015","journal-title":"Nanoscale"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"9884","DOI":"10.1021\/nn500188y","article-title":"Hybrid nanotrimers for dual T1 and T2-weighted magnetic resonance imaging","volume":"8","author":"Cheng","year":"2014","journal-title":"ACS Nano"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"102261","DOI":"10.1016\/j.cis.2020.102261","article-title":"Absorption, distribution, metabolism, and excretion of nanocarriers in vivo and their influences","volume":"284","author":"Zhang","year":"2020","journal-title":"Adv. Colloid Interface Sci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.tips.2021.05.001","article-title":"Iron metabolism: Pathophysiology and Pharmacology","volume":"42","author":"Roemhild","year":"2021","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12017-009-8108-8","article-title":"From Manganism to Manganese-Induced Parkinsonism: A Conceptual Model Based on the Evolution of Exposure","volume":"11","author":"Lucchini","year":"2009","journal-title":"Neuromol. Med."},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Alromi, D.A., Madani, S.Y., and Seifalian, A. (2021). Emerging application of magnetic nanoparticles for diagnosis and treatment of cancer. Polymers, 13.","DOI":"10.3390\/polym13234146"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/nbt1340","article-title":"Renal clearance of nanoparticles","volume":"25","author":"Choi","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1166\/jnn.2015.9585","article-title":"Applications of Magnetic Nanoparticles in Targeted Drug Delivery System","volume":"15","author":"Mou","year":"2015","journal-title":"J. Nanosci. Nanotechnol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"041321","DOI":"10.1063\/5.0061530","article-title":"Smart transformable nanoparticles for enhanced tumor theranostics","volume":"8","author":"Chen","year":"2021","journal-title":"Appl. Phys. Rev."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"20150207","DOI":"10.1259\/bjr.20150207","article-title":"Applications of nanoparticles for diagnosis and therapy of cancer","volume":"88","author":"Baetke","year":"2015","journal-title":"Br. J. Radiol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/01.rli.0000191370.52737.75","article-title":"The cost of developing imaging agents for routine clinical use","volume":"41","author":"Nunn","year":"2006","journal-title":"Investig. Radiol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2967\/jnumed.112.107615","article-title":"Barriers to clinical translation with diagnostic drugs","volume":"54","author":"Josephson","year":"2013","journal-title":"J. Nucl. Med."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/6\/1352\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:15:38Z","timestamp":1760105738000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/6\/1352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,18]]},"references-count":137,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["molecules29061352"],"URL":"https:\/\/doi.org\/10.3390\/molecules29061352","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,18]]}}}